Craig Tanio, MD, FACP

Dr. Tanio is trained in internal medicine, brain health, longevity, and precision medicine. As co-founder of Rezilir Health, he leads a clinical team treating complex chronic conditions such as cognitive decline, neurodegenerative disorders, Long Covid, autoimmune diseases, ME/CFS, and environmentally acquired illnesses. His approach emphasizes identifying root causes and providing practical, evidence-based care, drawing from multiple medical disciplines and aligning with patients' values and preferences.He holds a BA in Political Science from UCLA, an M.D. from UCSF, and an MBA from the Wharton School. He completed his residency and fellowship at the University of Pennsylvania, where he served as Chief Medical Resident and was a Robert Wood Johnson Clinical Scholar. Dr. Tanio is board certified in internal and functional medicine and has trained in several functional protocols.He is a co-investigator in the Evanthea Research Study, which explores reversing cognitive decline through precision medicine, and leads studies on real-world outcomes for patients with cognitive decline and ME/CFS. His leadership roles have included serving as Chief Medical Officer of ChenMed, a multi-state group practice for Medicare Advantage patients, a Partner at McKinsey & Company and Chairman of the Maryland Health Care Commission. He is also on the faculty at Johns Hopkins and Nova Southeastern University and is a member of the Alpha Omega Alpha Medical Honor Society.